Vanderbilt Institute for Clinical and Translational Research (VICTR)

September 27, 2018

Clinic helps adults clarify true status of penicillin allergy

By Bill Snyder
August 14, 2018

Medically underserved women in the Southeast rarely receive BRCA tests

Medically underserved women in the Southeast diagnosed with breast cancer or ovarian cancer missed out on genetic testing that could have helped them and their relatives make important decisions about their health, according to new research from Vanderbilt-Ingram Cancer Center.

By Tom Wilemon
April 19, 2018

VUMC drug repurposing initiative gaining momentum

Drug repurposing involves establishing an additional approved indication for a drug already at market.

By Paul Govern
Illustration of human intestinal tract
March 22, 2018

Grant bolsters study of potential new therapy for C. diff infection

According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis.

By Paul Govern
March 1, 2018

Study reveals safety signal from genes that mimic drugs

Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center.

By Paul Govern
February 8, 2018

Event showcases REDCap’s data management versatility

Fourteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has transformed clinical and translational studies around the globe.

By Bill Snyder
October 13, 2017

Exhibit translates scientific discoveries into art celebrating Vanderbilt’s Nobel laureates

A new exhibit on display at the Wond'ry honors the discoveries of Vanderbilt's Nobel laureates by translating them into beautiful works of art.
September 21, 2017

New lab formulary improves quality, cuts cost

An effort at Vanderbilt University Medical Center (VUMC) to enhance clinical decision making through cross-departmental collaboration and effective use of diagnostics has improved patient care and saved the institution more than $1 million in 2016, VUMC officials reported this week.
By Bill Snyder
September 21, 2017

Translational Research Forum set for Oct. 13

Jacob Corn, Ph.D., a pioneer in next-generation genome editing at the University of California Berkeley, will be the guest speaker at the 2017 Vanderbilt Translational Research Forum Oct. 13 at the Student Life Center.
By Bill Snyder
September 7, 2017

Community key to gender identity research effort

One of the key elements of the Vanderbilt Program for LGBTI Health, an innovative effort to improve health care for lesbian, gay, bisexual, transgender and intersex patients, is community engagement.
By Kathy Whitney
August 7, 2017

Vanderbilt begins Phase 1 trials of new Alzheimer’s drug

Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.
By Bill Snyder
July 13, 2017

Lindsell named to key VICTR, IMPH and Biostatistics leadership roles

Christopher Lindsell, Ph.D., nationally known for building clinical, translational and emergency medicine research programs at the University of Cincinnati, has been named director of the Research Methods Program in the Vanderbilt Institute of Clinical and Translational Research (VICTR).
By Bill Snyder
June 8, 2017

VUMC lands renewal of Clinical and Translational Science Award

Vanderbilt University Medical Center (VUMC) has competed successfully for a second renewal of its Clinical and Translational Science Award (CTSA) by the National Institutes of Health (NIH).
By Bill Snyder
1 … 3 4 5 6 7 8